Interactions on record — worth a quick check against your medications. Check your meds →
Dietary supplement

Virasara Ingredients & Drug Interactions

by EuroMedica

Virasara label
See full label image
Softgel Capsule Category: Botanical
Most serious interaction: Moderate
Clinical methodology reviewed by · Updated Sep 16, 2026 · Label data from the NIH DSLD
What is this page for?

First and foremost: checking Virasara against your medications. The heart of this page is the interaction checker and the full interaction report — how this product’s ingredients may interact with prescription and over-the-counter medicines you may be taking.

Around that, we add a pharmacist’s high-level view of the product as a whole — what’s inside, the evidence for its stated use, how transparent the label is, and what safety data exists — so you can see the full picture in one place. It’s educational information from our licensed clinical databases and the clinical staff at HelloPharmacist — not medical advice — and we don’t sell or endorse products. Our editorial policy

The interaction bottom line Most serious interaction: Moderate

Virasara is a dietary supplement by EuroMedica with 4 active ingredients. Its ingredients are commonly taken for cough and respiratory congestion, sore throat, digestive upset.Based on those ingredients, 916 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are Thyme (Thymus satureioides) flower oil, Ravintsara (Cinnamomum camphora) leaf oil, Bay Laurel (Laurus nobilis) leaf oil. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.

Jump to a section

Check Your Meds Against Virasara by EuroMedica

Ask about any prescription or over-the-counter medication and we check it for interactions with Virasara by EuroMedica — and tell you which ingredient is responsible.

Pharmacist-reviewed data Checks every ingredient Answer in seconds
Prefer a human? Send your question to our licensed pharmacists — free, answered by email within 24 hours.
Computed from our clinical databases

HelloPharmacist Scorecard of Virasara by EuroMedica

Four independent checks of what is known — a summary of the available information, not a grade of the product itself.

Evidence for Intended Use
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
Not assessable

The stated purpose hasn't been mapped to our evidence data yet.

Why this rating?
  • We haven't mapped this product's purpose to our evidence data yet — it'll be graded on the next content refresh.
Ingredient Transparency
Low

Most active ingredients don't disclose an individual amount — you can't tell how much of each you're getting.

Why this rating?
  • The label discloses an exact amount for 0 of its 4 active ingredients.
  • “Proprietary Formula” is a proprietary blend — the label gives one combined amount (200 mg) without saying how much of each component you get.
Known Interaction Concern
Moderate identified

The most serious documented interaction for these ingredients is Moderate. Check your medications for a personalized result.

Why this rating?
  • 3 of the 4 matched ingredients can interact with medications — Bay Leaf, Camphor, Thyme.
  • The most serious interaction on file is rated Moderate.
  • Some involve high-stakes drug classes: anticoagulant / antiplatelet drugs; diabetes medications.
  • For scale: 917 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.
Safety Information
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 4 of the 4 matched ingredients.
  • Pregnancy & breastfeeding safety ratings cover 4 of 4.
  • General safety write-ups exist for 4 of 4.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

HelloPharmacist summaryFormula with limited ingredient disclosure with no assessable stated purpose. Moderate medication interactions have been identified, and safety information is well characterized.

Assessment coverage: 4 of 4 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Oct 22, 2015.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about Virasara, straight from the product label.

Brand EuroMedica
Barcode (UPC) 367703803230
Net contents 30 Softgel(s)
Market status Off market
Date entered into DSLD Oct 22, 2015
DSLD ID 52963
Product type Botanical
Supplement form Softgel Capsule
Dietary claims / uses All Other, Structure/Function
Intended target group(s) Adult (18 - 50 Years), Gluten Free, Dairy Free, Sugar Free
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for Virasara by EuroMedica, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
1 Softgel(s)
Maximum serving Sizes:
1 Softgel(s)
Servings per container
30
UPC/BARCODE
367703803230
IngredientAmount% DV
Proprietary Formula200 mg--
Thyme (Thymus satureioides) flower oil0 NP--
Ravintsara (Cinnamomum camphora) leaf oil0 NP--
Myrtle (Myrtus communis) leaf oil0 NP--
Bay Laurel (Laurus nobilis) leaf oil0 NP--

Other ingredients: extra virgin olive oil, Gelatin, Glycerin, Water

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
General Statements

100% Pure, Bio-Typed Plant Oils

Bio-Typed Plant Oils can be up to 100 times more concentrated than dry herbs.

- Provides strong immune defense support - Supports bronchial airways - Supports energy levels and a feeling of well-being*

Powerful Immune Support

100% Bio-Typed Plant Oils

Product of Belgium

Brand IP Statement(s)

Virasara provides a synergistic blend of powerful, Bio-Typed plant oils to support immune health and well-being.

Suggested/Recommended/Usage/Directions

Recommendations: 1 softgel daily. May increase to 1 softgel three times daily if additional support is required, or as directed by your healthcare practitioner.

Precautions

If pregnant or nursing, consult a health care practitioner before using.

FDA Disclaimer Statement

THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE.

General

JC 34 91 + 3(5,6)EM L80323.03

FDA Statement of Identity

DIETARY SUPPLEMENT

Formulation

No sugar, salt, yeast, wheat, gluten, corn, soy, dairy products, artificial coloring, artificial flavoring, or artificial preservatives.

Non-GMO

Is this label outdated? Report a formula or label change and our pharmacy team will review it.

See for yourself

Virasara by EuroMedica label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

Virasara label

Label images are published by the NIH Dietary Supplement Label Database for the version of this product on file. Always read your actual product label.

View the full label (PDF)
What’s inside

The Ingredients in Virasara by EuroMedica

These are the 4 active ingredients this product is made of. Select any to open its full monograph.

Serving size1 Softgel(s) Dosage formSoftgel Capsule Servings per container30 Amounts shown are per serving.

Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.

Other (inactive) ingredients: Extra virgin olive oil, Gelatin, Glycerin, Water. These complete the product’s ingredient list but are not active constituents.

Interaction report

Virasara by EuroMedica Drug Interactions

Virasara contains 4 ingredients, and 3 of them have known drug interactions. Altogether they interact with 916 medications. Here’s the picture, then you can look up your own drug.

Want to check YOUR meds against Virasara?

Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.

 Go to the checker
916Drugs
916 Moderate

Ingredients driving the most interactions

Thyme (Thymus satureioides) flower oil 379
Ravintsara (Cinnamomum camphora) leaf oil 370
Bay Laurel (Laurus nobilis) leaf oil 335

Individual Drug Interactions

The ingredients in Virasara interact with 916 drugs. Click any drug to see the details.

3 of the 4 ingredients in Virasara interact with drugs. Each result below shows which ingredient is responsible. Thyme (Thymus satureioides) flower oil Ravintsara (Cinnamomum camphora) leaf oil Bay Laurel (Laurus nobilis) leaf oil

Each ingredient & the kinds of drugs it affects

For each ingredient in Virasara with known interactions, here are the types of medications they can affect. Open any type for the detail — or search your exact drug in the checker above.

Thyme (Thymus satureioides) flower oil4 drug types · 379 drugs

Anticholinergic Drugs

Theoretically, concurrent use of anticholinergic drugs and thyme essential oil might reduce the effects of anticholinergic drugs.
In vitro evidence suggests that thyme essential oil and specific essential oil constituents like thymohydroquinone and carvacrol can inhibit acetylcholinesterase (AChE). However, this effect has not been observed in humans.

Likelihood Possible Evidence D
Anticoagulant/Antiplatelet Drugs

Theoretically, thyme leaf extract might have additive effects with anticoagulant or antiplatelet drugs.
In vitro and animal research suggests that thyme leaf extract has antiplatelet effects. However, this effect has not been observed in humans.

Likelihood Possible Evidence D
Cholinergic Drugs

Theoretically, concurrent use of cholinergic drugs and thyme essential oil might cause additive cholinergic effects.
In vitro evidence suggests that thyme essential oil and specific essential oil constituents like thymohydroquinone and carvacrol can inhibit acetylcholinesterase (AChE). However, this effect has not been observed in humans.

Likelihood Possible Evidence D
Estrogens

Theoretically, thyme might competitively inhibit the effects of estrogen replacement therapy.
In vitro research shows that thyme has estrogen receptor-binding activity and phytoestrogen content. However, this effect has not been observed in humans.

Likelihood Possible Evidence D
Thyme (Thymus satureioides) flower oil full monograph & interactions

Ravintsara (Cinnamomum camphora) leaf oil1 drug type · 370 drugs

Hepatotoxic Drugs

Theoretically, concomitant use of camphor with other hepatotoxic drugs might increase the risk of liver damage.
There have been a few case reports of transient elevations in liver enzymes in adults after oral or topical use of camphor. There has also been one case of hepatotoxicity in an infant after topical camphor use.

Likelihood Possible Evidence D
Ravintsara (Cinnamomum camphora) leaf oil full monograph & interactions

Bay Laurel (Laurus nobilis) leaf oil3 drug types · 335 drugs

Antidiabetes Drugs

Concomitant use of bay leaf with antidiabetes drugs might increase the risk of hypoglycemia.
Preliminary clinical research shows that bay leaf can lower blood glucose levels in patients with diabetes who are already taking antidiabetes medication. Advise patients to monitor glucose levels closely. Dose adjustments may be necessary.

Likelihood Possible Evidence D
Cns Depressants

Theoretically, taking bay leaf in large amounts may enhance the therapeutic and adverse effects of sedatives.
Bay leaf contains methyl eugenol. Animal research shows that methyl eugenol has sedative properties. Avoid concomitant use.

Likelihood Possible Evidence D
Narcotic Drugs

Theoretically, taking bay leaf in large amounts may enhance the therapeutic and adverse effects of narcotics. Avoid concomitant use.

Likelihood Possible Evidence D
Bay Laurel (Laurus nobilis) leaf oil full monograph & interactions
The maker

Brand information

Manufacturer and brand details for Virasara, from the product label.

EuroMedica

See all EuroMedica products
Name
EuroMedica
Street Address
955 Challenger Dr.
City
Green Bay
State
WI
ZipCode
54311
Phone Number
866-842-7256
Web Address
www.EuroMedicaUSA.com
Pharmacist Counseling Corner

Virasara by EuroMedica: Common Questions

Does Virasara by EuroMedica interact with any medications?
Yes. Based on its ingredients, Virasara has a known interaction with 916 medications. Use the checker to see how it interacts with a specific drug.
How can one product interact with so many drugs?
Virasara contains 4 active ingredients, and an interaction can come from any of them. We check every ingredient, combine the results into one list per medication, and show which ingredient and mechanism is responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if Virasara is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

Virasara label
Go deeper

The Full Monographs Behind Virasara’s Ingredients

Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.

Herb & supplement monograph

Thyme

Interacts with 379 drugs

Thyme is a common kitchen herb that has long been used for coughs, sore throats, and digestive complaints. It is generally safe in the amounts found in food, and some cough products that com...

Read the full Thyme monograph → Herb & supplement monograph

Camphor

Interacts with 370 drugs

Camphor is a strong-smelling compound from the camphor tree (or made synthetically) that is used in many topical rub-on products for muscle aches, itching, and chest congestion. It can be he...

Read the full Camphor monograph → Herb & supplement monograph

Myrtle

Myrtle (Myrtus communis) is a Mediterranean shrub used traditionally for respiratory, digestive, and skin complaints. Modern research is mostly limited to laboratory and small studies, so it...

Read the full Myrtle monograph → Herb & supplement monograph

Bay Leaf

Interacts with 335 drugs

Bay leaf is a common culinary herb that is safe in the small amounts used in cooking. Some people take it for digestion, blood sugar, or colds, but strong human evidence for these uses is la...

Read the full Bay Leaf monograph →
Sources

Sources & How We Checked

Virasara's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 48 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Thyme 18 references
  1. Zava DT, Dollbaum CM, Blen M. Estrogen and progestin bioactivity of foods, herbs, and spices. Proc Soc Exp Biol Med 1998;217:369-78. PubMed
  2. Electronic Code of Federal Regulations. Title 21. Part 182 -- Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
  3. Okazaki K, Kawazoe K, Takaishi Y. Human platelet aggregation inhibitors from thyme (Thymus vulgaris L.). Phytother Res 2002;16:398-9. .
  4. Spiewak R, Skorska C, Dutkiewicz J. Occupational airborne contact dermatitis caused by thyme dust. Contact Dermatitis 2001;44:235-9. . PubMed
  5. Ernst E, Marz R, Sieder C. A controlled multi-centre study of herbal versus synthetic secretolytic drugs for acute bronchitis. Phytomedicine 1997;4:287-93. PubMed
  6. Yamamoto J, Yamada K, Naemura A, et al. Testing various herbs for antithrombotic effect. Nutrition 2005;21(5):580-7. PubMed
  7. Tognolini, M., Barocelli, E., Ballabeni, V., Bruni, R., Bianchi, A., Chiavarini, M., and Impicciatore, M. Comparative screening of plant essential oils: phenylpropanoid moiety as basic core for antiplatelet activity. Life Sci. 2-23-2006;78(13):1419-1432. PubMed
  8. Mackiewicz, B., Skorska, C., Dutkiewicz, J., Michnar, M., Milanowski, J., Prazmo, Z., Krysinska-Traczyk, E., and Cisak, E. Allergic alveolitis due to herb dust exposure. Ann Agric Environ Med 1999;6(2):167-170.
  9. Martinez-Gonzalez, M. C., Goday Bujan, J. J., Martinez, Gomez W., and Fonseca, Capdevila E. Concomitant allergic contact dermatitis due to Rosmarinus officinalis (rosemary) and Thymus vulgaris (thyme). Contact Dermatitis 2007;56(1):49-50.
  10. Jukic, M., Politeo, O., Maksimovic, M., Milos, M., and Milos, M. In vitro acetylcholinesterase inhibitory properties of thymol, carvacrol and their derivatives thymoquinone and thymohydroquinone. Phytother.Res 2007;21(3):259-261.
  11. Marzian, O. [Treatment of acute bronchitis in children and adolescents. Non-interventional postmarketing surveillance study confirms the benefit and safety of a syrup made of extracts from thyme and ivy leaves]. MMW.Fortschr.Med 6-28-2007;149(27-28 Suppl
  12. Cuzzolin, L. and Benoni, G. Attitudes and knowledge toward natural products safety in the pharmacy setting: an Italian study. Phytother.Res 2009;23(7):1018-1023. PubMed
  13. Berova, N., Stransky, L., and Krasteva, M. Studies on contact dermatitis in stomatological staff. Dermatol.Monatsschr. 1990;176(1):15-18.
  14. Smeenk, G., Kerckhoffs, H. P., and Schreurs, P. H. Contact allergy to a reaction product in Hirudoid cream: an example of compound allergy. Br.J Dermatol. 1987;116(2):223-231.
  15. Le Roy, R., Grosshans, E., and Foussereau, J. [Investigation of contact allergies in 100 cases of ulcus cruris (author's transl)]. Derm.Beruf.Umwelt. 1981;29(6):168-170.
  16. Lorenzi, S., Placucci, F., Vincenzi, C., Bardazzi, F., and Tosti, A. Allergic contact dermatitis due to thymol. Contact Dermatitis 1995;33(6):439-440. PubMed
  17. Bahadoran P, Rokni FK, Fahami F. Investigating the therapeutic effect of vaginal cream containing garlic and thyme compared to clotrimazole cream for the treatment of mycotic vaginitis. Iran J Nurs Midwifery Res 2010;15(Suppl 1):343-9.
  18. Erol S, Aydin B, Dilli D, Okumus N, Zenciroglu A, Gündüz M. An interesting newborn case of fructose 1-6 diphosphatase deficiency triggered after thyme juice ingestion. Clin Lab. 2014;60(1):151-3. PubMed

See these in context on the Thyme monograph →

Camphor 20 references
  1. Uc A, Bishop WP, Sanders KD. Camphor hepatotoxicity. South Med J 2000;93:596-8. DOI
  2. Love JN, Sammon M, Smereck J. Are one or two dangerous? Camphor exposure in toddlers. J Emerg Med 2004;27:49-54.. PubMed
  3. Ruha AM, Graeme KA, Field A. Late seizure following ingestion of Vicks VapoRub. Acad Emerg Med 2003;10:691. . PubMed
  4. Gouin S, Patel H. Unusual cause of seizure. Pediatr Emerg Care 1996;12:298-300. DOI
  5. Ernst E. Adverse effects of herbal drugs in dermatology. Br J Dermatol 2000;143:923-9. PubMed
  6. Fung AE, Oxford KW. Microwave-superheated Vics Vapo Rub: an ocular public health danger. Am J Ophthalmol 2004;137:379-80. PubMed
  7. Emery, D. P. and Corban, J. G. Camphor toxicity. J.Paediatr.Child Health 1999;35(1):105-106.
  8. Rampini, S. K., Schneemann, M., Rentsch, K., and Bachli, E. B. Camphor intoxication after cao gio (coin rubbing). JAMA 7-3-2002;288(1):45.
  9. SMITH, A. G. and MARGOLIS, G. Camphor poisoning; anatomical and pharmacologic study; report of a fatal case; experimental investigation of protective action of barbiturate. Am.J.Pathol. 1954;30(5):857-869.
  10. Ragucci, K. R., Trangmar, P. R., Bigby, J. G., and Detar, T. D. Camphor ingestion in a 10-year-old male. South.Med.J. 2007;100(2):204-207. PubMed
  11. Agarwal, A. and Malhotra, H. S. Camphor ingestion: an unusual cause of seizure. J.Assoc.Physicians India 2008;56:123-124.
  12. Weiss, J. and Catalano, P. Camphorated oil intoxication during pregnancy. Pediatrics 1973;52(5):713-714. DOI
  13. Vasey, R. H. and Karayannopoulos, S. J. Camphorated oil. Br.Med.J. 1-8-1972;1(5792):112.
  14. Mascie-Taylor, B. H., Widdop, B., and Davison, A. M. Camphor intoxication treated by charcoal haemoperfusion. Postgrad.Med.J. 1981;57(673):725-726. PubMed
  15. Theis, J. G. and Koren, G. Camphorated oil: still endangering the lives of Canadian children. CMAJ. 6-1-1995;152(11):1821-1824.
  16. Skoglund, R. R., Ware, L. L., Jr., and Schanberger, J. E. Prolonged seizures due to contact and inhalation exposure to camphor. A case report. Clin.Pediatr.(Phila) 1977;16(10):901-902. PubMed
  17. Cordoba Torres IT, Marino-Nieto J, Barkin HB, Fort AC, Cobas M. Vicks VapoRub intoxication: an unusual presentation of multiorgan failure. J Clin Anesth 2018;48:46-7. PubMed
  18. Rahimi M, Shokri F, Hassanian-Moghaddam H, et al. Severe camphor poisoning, a seven-year observational study. Environ Toxicol Pharmacol 2017;52:8-13. PubMed
  19. Mathew T, John SK, Kamath V, et al. Essential oil related seizures (EORS): A multi-center prospective study on essential oils and seizures in adults. Epilepsy Res. 2021;173:106626. PubMed
  20. Camphor (synthetic): Immediately Dangerous to Life or Health Concentrations (IDLH). National Institute for Occupational Safety and Health. 1994. https://www.cdc.gov/niosh/idlh/76222.html. Assessed 5/6/2021.

See these in context on the Camphor monograph →

Myrtle 3 references
  1. Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. 1st ed. Montvale, NJ: Medical Economics Company, Inc., 1998.
  2. Salmanian M, Shirbeigi L, Hashem-Dabaghian F, et al. The Effects of Myrtle (Myrtus communis) and Clindamycin Topical Solution in the Treatment of Mild to Moderate Acne Vulgaris: A Comparative Split-Face Study. J Pharmacopuncture 2020;23(4):220-229.
  3. Paknejad MS, Eftekhari K, Rahimi R, Vigeh M, Naghizadeh A, Karimi M. Myrtle (Myrtus communis L.) fruit syrup for gastroesophageal reflux disease in children: A double-blind randomized clinical trial. Phytother Res 2021;35(11):6369-6376.

See these in context on the Myrtle monograph →

Bay Leaf 7 references
  1. Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics. 2nd ed. New York, NY: John Wiley & Sons, 1996.
  2. Cartier LC, Lehrer A, Malo JL. Occupational asthma caused by aromatic herbs. Allergy 1996;51:647-9. DOI
  3. Adisen E, Onder M. Allergic contact dermatitis from Laurus nobilis oil induced by massage. Contact Dermatitis 2007;56:360-1.
  4. Ozden, M. G., Oztas, P., Oztas, M. O., and Onder, M. Allergic contact dermatitis from Laurus nobilis (laurel) oil. Contact Dermatitis 2001;45(3):178. PubMed
  5. Khan, A., Zaman, G., and Anderson, R. A. Bay leaves improve glucose and lipid profile of people with type 2 diabetes. J Clin Biochem.Nutr. 2009;44(1):52-56. PubMed
  6. Cheminat, A., Stampf, J. L., and Benezra, C. Allergic contact dermatitis to laurel (Laurus nobilis L.): isolation and identification of haptens. Arch Dermatol Res 1984;276(3):178-181. PubMed
  7. Vassileva S, Darlenski R. Bay leaf phytodermatitis. Contact Dermatitis. 2020 Nov 15. PubMed

See these in context on the Bay Leaf monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring
Supplement interaction checker › Check any supplement or product against your medications Drug–drug interactions › Check two or more of your medications against each other Browse medications A–Z › Every drug we've checked against herbs & supplements NDC & pricing lookup › Find a drug’s NDCs, packaging and costs Ask a pharmacist › Free, personal answer from our licensed team